Despite the recent progress in identifying such pathogenic targets of RNF213, the identity of human substrates targeted for ubiquitination by RNF213 remains extremely limited [20,21], thus hampering progress in clarifying its direct in vivo functions and signal control mechanisms and its role in vasculopathies such as MMD. The gene discussed is RNF213; the disease is multiminicore myopathy.